每年出版 6 期
ISSN 打印: 1040-8401
ISSN 在线: 2162-6472
Indexed in
The Proteasome and Its Inhibitors in Immune Regulation and Immune Disorders
摘要
The ubiquitin-proteasome pathway is a well-characterized mechanism deputed to the degradation of intracellular proteins. Proteasomal degradation intervenes in the regulation of numerous cellular functions including signal transduction, apoptosis, cell cycle, and antigen presentation. In vitro and in vivo studies have shown that both normal and malignant cells of the immune system are exquisitely affected by inhibition of proteasome activity. This property is currently exploited in the treatment of multiple myeloma and mantle cell lymphoma, two B-cell malignancies that respond to treatment with the proteasome inhibitor bortezomib. Pharmacological inhibitors of the proteasome also affect function and survival of B and T lymphocytes and of dendritic cells and were shown to reduce autoimmune and inflammatory manifestations in several models of immune-mediated disorders. The present review offers an overview of the mechanisms implicated in the immunomodulatory effects of proteasome inhibitors and discusses prospective future applications for these small molecules in immune and inflammatory diseases.
-
Stübgen Joerg-Patrick, Drug-induced dysimmune demyelinating neuropathies, Journal of the Neurological Sciences, 307, 1-2, 2011. Crossref
-
Chen Chen, Meng Yan, Wang Lei, Wang Hong-Xia, Tian Cui, Pang Guo-Dong, Li Hui-Hua, Du Jie, Ubiquitin-activating enzyme E1 inhibitor PYR41 attenuates angiotensin II-induced activation of dendritic cells via the IκBa/NF-κB and MKP1/ERK/STAT1 pathways, Immunology, 142, 2, 2014. Crossref
-
Turchan-Cholewo Jadwiga, Dimayuga Filomena O., Gupta Sunita, Keller Jeffrey N., Knapp Pamela E., Hauser Kurt F., Bruce-Keller Annadora J., Morphine and HIV-Tat increase microglial-free radical production and oxidative stress: possible role in cytokine regulation, Journal of Neurochemistry, 108, 1, 2009. Crossref
-
Pilecka Iwona, Sadowski Lukasz, Kalaidzidis Yannis, Miaczynska Marta, Recruitment of APPL1 to ubiquitin-rich aggresomes in response to proteasomal impairment, Experimental Cell Research, 317, 8, 2011. Crossref
-
Finn Jonathan D, Hui Daniel, Downey Harre D, Dunn Danielle, Pien Gary C, Mingozzi Federico, Zhou Shangzhen, High Katherine A, Proteasome Inhibitors Decrease AAV2 Capsid derived Peptide Epitope Presentation on MHC Class I Following Transduction, Molecular Therapy, 18, 1, 2010. Crossref
-
Vázquez Jesús, García-Jareño Alicia, Mondragón Laura, Rubio-Martinez Jaime, Pérez-Payá Enrique, Albericio Fernando, Conformationally Restricted Hydantoin-Based Peptidomimetics as Inhibitors of Caspase-3 with Basic Groups Allowed at the S3 Enzyme Subsite, ChemMedChem, 3, 6, 2008. Crossref
-
Ravaglia Sabrina, Corso Alessandro, Piccolo Giovanni, Lozza Alessandro, Alfonsi Enrico, Mangiacavalli Silvia, Varettoni Marzia, Zappasodi Patrizia, Moglia Arrigo, Lazzarino Mario, Costa Alfredo, Immune-mediated neuropathies in myeloma patients treated with bortezomib, Clinical Neurophysiology, 119, 11, 2008. Crossref
-
Corredor Miriam, Garrido Maria, Bujons Jordi, Orzáez Mar, Pérez‐Payá Enrique, Alfonso Ignacio, Messeguer Angel, Efficient Synthesis of Conformationally Restricted Apoptosis Inhibitors Bearing a Triazole Moiety, Chemistry – A European Journal, 21, 40, 2015. Crossref
-
Al-Homsi Ahmad-Samer, Cole Kelli, Bogema Marlee, Duffner Ulrich, Williams Stephanie, Mageed Aly, Short Course of Post-Transplantation Cyclophosphamide and Bortezomib for Graft-versus-Host Disease Prevention after Allogeneic Peripheral Blood Stem Cell Transplantation Is Feasible and Yields Favorable Results: A Phase I Study, Biology of Blood and Marrow Transplantation, 21, 7, 2015. Crossref
-
Lin Amy Erica, Mak Tak W, The role of E3 ligases in autoimmunity and the regulation of autoreactive T cells, Current Opinion in Immunology, 19, 6, 2007. Crossref
-
Cenci Simone, The Proteasome in Terminal Plasma Cell Differentiation, Seminars in Hematology, 49, 3, 2012. Crossref
-
Khalturin Konstantin, Anton-Erxleben Friederike, Milde Sabine, Plötz Christine, Wittlieb Jörg, Hemmrich Georg, Bosch Thomas C.G., Transgenic stem cells in Hydra reveal an early evolutionary origin for key elements controlling self-renewal and differentiation, Developmental Biology, 309, 1, 2007. Crossref
-
Vana P. Geoff, LaPorte Heather M., Wong Yee M., Kennedy Richard H., Gamelli Richard L., Majetschak Matthias, Proteasome Inhibition After Burn Injury, Journal of Burn Care & Research, 37, 4, 2016. Crossref
-
Toema Bassem, El-Sweilmeen Hamdan, Helmy Tarek, Oculomotor nerve palsy associated with bortezomib in a patient with multiple myeloma: a case report, Journal of Medical Case Reports, 4, 1, 2010. Crossref
-
Kaplan Gulce Sari, Torcun Ceyda Corek, Grune Tilman, Ozer Nesrin Kartal, Karademir Betul, Proteasome inhibitors in cancer therapy: Treatment regimen and peripheral neuropathy as a side effect, Free Radical Biology and Medicine, 103, 2017. Crossref
-
Eldor Roy, Abel Roy, Sever Dror, Sadoun Gad, Peled Amnon, Sionov Ronit, Melloul Danielle, Maedler Kathrin, Inhibition of Nuclear Factor-κB Activation in Pancreatic β-Cells Has a Protective Effect on Allogeneic Pancreatic Islet Graft Survival, PLoS ONE, 8, 2, 2013. Crossref
-
Bosch Thomas C. G., Stem Cells in Immortal Hydra, in Stem Cells, 2008. Crossref
-
Wang Xin Shelley, Shi Qiuling, Mendoza Tito R., Garcia-Gonzalez Araceli, Chen Ting-Yu, Kamal Mona, Chen Tsun Hsuan, Heijnen Cobi, Orlowski Robert Z., Cleeland Charles S., Minocycline for symptom reduction in patients with multiple myeloma during maintenance therapy: a phase II placebo-controlled randomized trial, Supportive Care in Cancer, 29, 10, 2021. Crossref
-
Xue Yan, Yun Dong, Esmon Alex, Zou Peng, Zuo Shuai, Yu Yanbao, He Fuchu, Yang Pengyuan, Chen Xian, Proteomic Dissection of Agonist-Specific TLR-Mediated Inflammatory Responses on Macrophages at Subcellular Resolution, Journal of Proteome Research, 7, 8, 2008. Crossref
-
Mondragón L., Orzáez M., Sanclimens G., Moure A., Armiñán A., Sepúlveda P., Messeguer A., Vicent M. J., Pérez-Payá E., Modulation of Cellular Apoptosis with Apoptotic Protease-Activating Factor 1 (Apaf-1) Inhibitors, Journal of Medicinal Chemistry, 51, 3, 2008. Crossref
-
Hwang Seungmin, Wu Ting-Ting, Tong Leming M., Kim Kyeong Seon, Martinez-Guzman DeeAnn, Colantonio Arnaud D., Uittenbogaart Christel H., Sun Ren, Persistent Gammaherpesvirus Replication and Dynamic Interaction with the Host In Vivo, Journal of Virology, 82, 24, 2008. Crossref